Utilization of healthcare services in acute myocardial infarction and the risk of out-of-hospital cardiac death

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27283933%3A_____%2F23%3AN0000026" target="_blank" >RIV/27283933:_____/23:N0000026 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/24:00135366 RIV/00216208:11120/24:43925923 RIV/00216208:11140/24:10466557 RIV/65269705:_____/24:00079449 a 6 dalších

Výsledek na webu

<a href="http://dx.doi.org/10.23736/S0031-0808.23.04910-8" target="_blank" >http://dx.doi.org/10.23736/S0031-0808.23.04910-8</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.23736/S0031-0808.23.04910-8" target="_blank" >10.23736/S0031-0808.23.04910-8</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Utilization of healthcare services in acute myocardial infarction and the risk of out-of-hospital cardiac death

Popis výsledku v původním jazyce

"Aim: To examine the impact of the COVID-19 pandemic on the relationship between in-hospital care utilization for acute myocardial infarction (IH-AMI) and out-of-hospital CV death (OH-CVD). Methods: The data was collected from the National Health Information System, namely the National Registry of Reimbursed Health Services, National Registry of Cardiovascular Surgery and Interventions, and Registry of Deaths in the Czech Republic, combined with data from the Information System of Infectious Diseases for COVID-19 data. We compared the pandemic (2020-2021) with the four years (2016-2019) before the pandemic. Results: The population for the analysis consisted of 64,291 AMI cases and 256,139 cases of OH-all cause deaths. IH-AMI expressed as numbers per 100,000 population have had a long-term stable trend: 104.8 in 2016, 104.5 in 2017, 99.3 in 2018, and 102.9 in 2019. In the pandemic (vs. 2016-2019), there was a significant reduction in IH-AMI. For acute IH-STEMI, the incidence RR (95% CI) was 0.956 (0.925; 0.987) in 2020 (43.0 per 100,000 population in 2020 vs. 45.0 in 2016-2019) and 0.905 (0.876; 0.936) in the second COVID-19 year (40.7 cases). The trend was the same for NSTEMI with an RR of 0.943 (0.911; 0.976) in 2020 and 0.911 (0.880; 0.943) in 2021. In addition to IH-AMI, the number of all CV disease-related hospitalizations declined by 375 cases per 100,000 population in 2020 and 400 in 2021. Moreover, during the 2020 lockdown year, there was an alarming decline in in-person outpatient clinic visits to internists and cardiologists (814 visits per 100,000 population). The rates of OH-CVD, which had been stable in the prepandemic years (191 in 2017, 196 in 2018, 193 in 2019 per 100,000 population), increased significantly in the COVID-19 period compared to the mean OH-CVD in 2016-2019; with an incidence RR of 1.193 (1.176; 1.210) in the first and 1.121 (1.105; 1.378) in the second year. Conclusion: Our analysis showed that any decrease in the hospitalization of patients with AMI, especially STEMI, can substantially increase OH-CVD."

Název v anglickém jazyce

Utilization of healthcare services in acute myocardial infarction and the risk of out-of-hospital cardiac death

Popis výsledku anglicky

"Aim: To examine the impact of the COVID-19 pandemic on the relationship between in-hospital care utilization for acute myocardial infarction (IH-AMI) and out-of-hospital CV death (OH-CVD). Methods: The data was collected from the National Health Information System, namely the National Registry of Reimbursed Health Services, National Registry of Cardiovascular Surgery and Interventions, and Registry of Deaths in the Czech Republic, combined with data from the Information System of Infectious Diseases for COVID-19 data. We compared the pandemic (2020-2021) with the four years (2016-2019) before the pandemic. Results: The population for the analysis consisted of 64,291 AMI cases and 256,139 cases of OH-all cause deaths. IH-AMI expressed as numbers per 100,000 population have had a long-term stable trend: 104.8 in 2016, 104.5 in 2017, 99.3 in 2018, and 102.9 in 2019. In the pandemic (vs. 2016-2019), there was a significant reduction in IH-AMI. For acute IH-STEMI, the incidence RR (95% CI) was 0.956 (0.925; 0.987) in 2020 (43.0 per 100,000 population in 2020 vs. 45.0 in 2016-2019) and 0.905 (0.876; 0.936) in the second COVID-19 year (40.7 cases). The trend was the same for NSTEMI with an RR of 0.943 (0.911; 0.976) in 2020 and 0.911 (0.880; 0.943) in 2021. In addition to IH-AMI, the number of all CV disease-related hospitalizations declined by 375 cases per 100,000 population in 2020 and 400 in 2021. Moreover, during the 2020 lockdown year, there was an alarming decline in in-person outpatient clinic visits to internists and cardiologists (814 visits per 100,000 population). The rates of OH-CVD, which had been stable in the prepandemic years (191 in 2017, 196 in 2018, 193 in 2019 per 100,000 population), increased significantly in the COVID-19 period compared to the mean OH-CVD in 2016-2019; with an incidence RR of 1.193 (1.176; 1.210) in the first and 1.121 (1.105; 1.378) in the second year. Conclusion: Our analysis showed that any decrease in the hospitalization of patients with AMI, especially STEMI, can substantially increase OH-CVD."

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Panminerva Medica

ISSN

0031-0808

e-ISSN

1827-1898

Svazek periodika

66

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

IT - Italská republika

Počet stran výsledku

3

Strana od-do

79-81

Kód UT WoS článku

001146442100001

EID výsledku v databázi Scopus

2-s2.0-85187724770